Annual Accounts Payable
$2.60 B
+$668.20 M+34.61%
31 December 2023
Summary:
Eli Lilly and Company annual accounts payable is currently $2.60 billion, with the most recent change of +$668.20 million (+34.61%) on 31 December 2023. During the last 3 years, it has risen by +$992.10 million (+61.75%). LLY annual accounts payable is now at all-time high.LLY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.89 B
-$38.30 M-1.31%
30 September 2024
Summary:
Eli Lilly and Company quarterly accounts payable is currently $2.89 billion, with the most recent change of -$38.30 million (-1.31%) on 30 September 2024. Over the past year, it has increased by +$451.40 million (+18.54%). LLY quarterly accounts payable is now -1.31% below its all-time high of $2.92 billion, reached on 30 June 2024.LLY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.6% | +18.5% |
| 3 y3 years | +61.8% | +84.2% |
| 5 y5 years | +115.3% | +158.9% |
LLY Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.8% | -1.3% | +101.4% |
| 5 y | 5 years | at high | +115.3% | -1.3% | +158.9% |
| alltime | all time | at high | +1224.6% | -1.3% | +1869.0% |
Eli Lilly And Company Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.89 B(-1.3%) |
| June 2024 | - | $2.92 B(+18.2%) |
| Mar 2024 | - | $2.47 B(-4.8%) |
| Dec 2023 | $2.60 B(+34.6%) | $2.60 B(+6.7%) |
| Sept 2023 | - | $2.44 B(-1.6%) |
| June 2023 | - | $2.47 B(+22.7%) |
| Mar 2023 | - | $2.02 B(+4.4%) |
| Dec 2022 | $1.93 B(+15.6%) | $1.93 B(+14.7%) |
| Sept 2022 | - | $1.68 B(+1.4%) |
| June 2022 | - | $1.66 B(+15.8%) |
| Mar 2022 | - | $1.43 B(-14.2%) |
| Dec 2021 | $1.67 B(+4.0%) | $1.67 B(+6.6%) |
| Sept 2021 | - | $1.57 B(-1.9%) |
| June 2021 | - | $1.60 B(-2.5%) |
| Mar 2021 | - | $1.64 B(+2.0%) |
| Dec 2020 | $1.61 B(+14.3%) | $1.61 B(+12.3%) |
| Sept 2020 | - | $1.43 B(+14.7%) |
| June 2020 | - | $1.25 B(+3.3%) |
| Mar 2020 | - | $1.21 B(-14.1%) |
| Dec 2019 | $1.41 B(+16.4%) | $1.41 B(+26.0%) |
| Sept 2019 | - | $1.11 B(-7.0%) |
| June 2019 | - | $1.20 B(+2.6%) |
| Mar 2019 | - | $1.17 B(-3.2%) |
| Dec 2018 | $1.21 B(-14.4%) | $1.21 B(-5.8%) |
| Sept 2018 | - | $1.28 B(-2.7%) |
| June 2018 | - | $1.32 B(+3.9%) |
| Mar 2018 | - | $1.27 B(-10.2%) |
| Dec 2017 | $1.41 B(+4.6%) | $1.41 B(+17.5%) |
| Sept 2017 | - | $1.20 B(-4.5%) |
| June 2017 | - | $1.26 B(+3.0%) |
| Mar 2017 | - | $1.22 B(-9.6%) |
| Dec 2016 | $1.35 B(+0.8%) | $1.35 B(+16.2%) |
| Sept 2016 | - | $1.16 B(-3.9%) |
| June 2016 | - | $1.21 B(+4.9%) |
| Mar 2016 | - | $1.15 B(-13.9%) |
| Dec 2015 | $1.34 B(+18.6%) | $1.34 B(+13.5%) |
| Sept 2015 | - | $1.18 B(+2.3%) |
| June 2015 | - | $1.15 B(-2.3%) |
| Mar 2015 | - | $1.18 B(+4.6%) |
| Dec 2014 | $1.13 B(+0.8%) | $1.13 B(+10.2%) |
| Sept 2014 | - | $1.02 B(-9.0%) |
| June 2014 | - | $1.12 B(-2.2%) |
| Mar 2014 | - | $1.15 B(+2.7%) |
| Dec 2013 | $1.12 B(-5.8%) | $1.12 B(-10.3%) |
| Sept 2013 | - | $1.25 B(+9.3%) |
| June 2013 | - | $1.14 B(+17.1%) |
| Mar 2013 | - | $974.40 M(-18.0%) |
| Dec 2012 | $1.19 B(+5.6%) | $1.19 B(-10.6%) |
| Sept 2012 | - | $1.33 B(+10.6%) |
| June 2012 | - | $1.20 B(-3.6%) |
| Mar 2012 | - | $1.25 B(+10.8%) |
| Dec 2011 | $1.13 B(+4.9%) | $1.13 B(-2.5%) |
| Sept 2011 | - | $1.15 B(-2.8%) |
| June 2011 | - | $1.19 B(+0.4%) |
| Mar 2011 | - | $1.18 B(+10.4%) |
| Dec 2010 | $1.07 B(+10.8%) | $1.07 B(+12.8%) |
| June 2010 | - | $950.30 M(-1.4%) |
| Mar 2010 | - | $964.00 M(-0.4%) |
| Dec 2009 | $968.10 M(+9.3%) | $968.10 M(+9.1%) |
| Sept 2009 | - | $887.70 M(-3.4%) |
| June 2009 | - | $918.60 M(-10.2%) |
| Mar 2009 | - | $1.02 B(+15.5%) |
| Dec 2008 | $885.80 M(-4.2%) | $885.80 M(+3.7%) |
| Sept 2008 | - | $854.40 M(+5.4%) |
| June 2008 | - | $810.70 M(+2.6%) |
| Mar 2008 | - | $789.80 M(-14.6%) |
| Dec 2007 | $924.40 M(+17.1%) | $924.40 M(+24.1%) |
| Sept 2007 | - | $744.90 M(+3.6%) |
| June 2007 | - | $719.30 M(+18.7%) |
| Mar 2007 | - | $606.00 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $789.40 M(+1.0%) | $789.40 M(+25.2%) |
| Sept 2006 | - | $630.60 M(-2.8%) |
| June 2006 | - | $648.90 M(+1.8%) |
| Mar 2006 | - | $637.70 M(-18.4%) |
| Dec 2005 | $781.30 M(+20.5%) | $781.30 M(+27.8%) |
| Sept 2005 | - | $611.30 M(+0.5%) |
| June 2005 | - | $608.50 M(-9.2%) |
| Mar 2005 | - | $670.50 M(+3.4%) |
| Dec 2004 | $648.60 M(-26.0%) | $648.60 M(-4.7%) |
| Sept 2004 | - | $680.40 M(-13.7%) |
| June 2004 | - | $788.80 M(-1.5%) |
| Mar 2004 | - | $800.50 M(-8.6%) |
| Dec 2003 | $875.90 M(+29.4%) | $875.90 M(+48.9%) |
| Sept 2003 | - | $588.30 M(+1.4%) |
| June 2003 | - | $580.10 M(-3.6%) |
| Mar 2003 | - | $602.00 M(-11.1%) |
| Dec 2002 | $676.90 M(+8.5%) | $676.90 M(+35.5%) |
| Sept 2002 | - | $499.40 M(-10.2%) |
| June 2002 | - | $555.90 M(+8.9%) |
| Mar 2002 | - | $510.40 M(-18.2%) |
| Dec 2001 | $624.10 M(-5.7%) | $624.10 M(+29.1%) |
| Sept 2001 | - | $483.40 M(+1.2%) |
| June 2001 | - | $477.50 M(-3.6%) |
| Mar 2001 | - | $495.40 M(-25.2%) |
| Dec 2000 | $661.90 M(+48.6%) | $661.90 M(+76.1%) |
| Sept 2000 | - | $375.90 M(-3.6%) |
| June 2000 | - | $390.00 M(-1.3%) |
| Mar 2000 | - | $395.00 M(-11.3%) |
| Dec 1999 | $445.50 M(-62.4%) | $445.50 M(+1.3%) |
| Sept 1999 | - | $439.90 M(+27.4%) |
| June 1999 | - | $345.20 M(+8.2%) |
| Mar 1999 | - | $319.00 M(-73.1%) |
| Dec 1998 | $1.19 B(+20.3%) | $1.19 B(+34.5%) |
| Sept 1998 | - | $881.80 M(-1.7%) |
| June 1998 | - | $897.10 M(+6.6%) |
| Mar 1998 | - | $841.40 M(-14.6%) |
| Dec 1997 | $985.50 M(+18.8%) | $985.50 M(+35.1%) |
| Sept 1997 | - | $729.50 M(-10.5%) |
| June 1997 | - | $815.40 M(+17.4%) |
| Mar 1997 | - | $694.80 M(-16.2%) |
| Dec 1996 | $829.30 M(-18.5%) | $829.30 M(+17.2%) |
| Sept 1996 | - | $707.50 M(-16.4%) |
| June 1996 | - | $845.90 M(+3.7%) |
| Mar 1996 | - | $815.40 M(-19.9%) |
| Dec 1995 | $1.02 B(+15.9%) | $1.02 B(+31.2%) |
| Sept 1995 | - | $776.10 M(-11.2%) |
| June 1995 | - | $874.10 M(+11.5%) |
| Mar 1995 | - | $783.70 M(-10.8%) |
| Dec 1994 | $878.20 M(+166.4%) | $878.20 M(+323.0%) |
| Sept 1994 | - | $207.60 M(-0.5%) |
| June 1994 | - | $208.70 M(-5.6%) |
| Mar 1994 | - | $221.00 M(-32.9%) |
| Dec 1993 | $329.60 M(+1.9%) | $329.60 M(+62.1%) |
| Sept 1993 | - | $203.30 M(-2.5%) |
| June 1993 | - | $208.50 M(-1.0%) |
| Mar 1993 | - | $210.50 M(-35.0%) |
| Dec 1992 | $323.60 M(+17.1%) | $323.60 M(+57.4%) |
| Sept 1992 | - | $205.60 M(+4.4%) |
| June 1992 | - | $196.90 M(-1.8%) |
| Mar 1992 | - | $200.50 M(-27.4%) |
| Dec 1991 | $276.30 M(+6.3%) | $276.30 M(+60.7%) |
| Sept 1991 | - | $171.90 M(-5.4%) |
| June 1991 | - | $181.80 M(-12.3%) |
| Mar 1991 | - | $207.30 M(-20.2%) |
| Dec 1990 | $259.90 M(+32.5%) | $259.90 M(+41.6%) |
| Sept 1990 | - | $183.60 M(-23.4%) |
| June 1990 | - | $239.80 M(+41.3%) |
| Mar 1990 | - | $169.70 M(-13.5%) |
| Dec 1989 | $196.20 M | $196.20 M(+33.8%) |
| Sept 1989 | - | $146.60 M(-6.0%) |
| June 1989 | - | $156.00 M |
FAQ
- What is Eli Lilly and Company annual accounts payable?
- What is the all time high annual accounts payable for Eli Lilly and Company?
- What is Eli Lilly and Company annual accounts payable year-on-year change?
- What is Eli Lilly and Company quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly accounts payable year-on-year change?
What is Eli Lilly and Company annual accounts payable?
The current annual accounts payable of LLY is $2.60 B
What is the all time high annual accounts payable for Eli Lilly and Company?
Eli Lilly and Company all-time high annual accounts payable is $2.60 B
What is Eli Lilly and Company annual accounts payable year-on-year change?
Over the past year, LLY annual accounts payable has changed by +$668.20 M (+34.61%)
What is Eli Lilly and Company quarterly accounts payable?
The current quarterly accounts payable of LLY is $2.89 B
What is the all time high quarterly accounts payable for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly accounts payable is $2.92 B
What is Eli Lilly and Company quarterly accounts payable year-on-year change?
Over the past year, LLY quarterly accounts payable has changed by +$451.40 M (+18.54%)